MKI67 and neoplasm: These findings taken together indicate that the LNR should be considered as an additional risk factor during the process of tumor risk assessment, and it does not suffice as an independent risk factor for prognosis in the setting of PNETs, especially not for patients with lower tumor grade Ki-67% or tumor size.